Midday Market Update: Wall Street Braces for Economic Reports
September 28, 2009 – U.S. stocks and exchange traded funds (ETFs) got a boost this morning as mergers and acquisitions activity encouraged investors. (more…) Continue Reading »

How the Race for a Cancer Drug Could Help Pharmaceutical ETFs
September 7, 2009 – Billions of dollars are being poured into cancer-fighting drugs. But it’s not just to find a cure – it’s also to gain market share in one of the most untapped markets, from a pharmaceutical... Continue Reading »

Midday Market Update: Markets Lose Luster on Earnings Reports
July 22, 2009 – Following a week long winning streak, mixed earnings reports put a damper on investor confidence and send stocks and exchange traded funds (ETFs) see-sawing in morning trading. (more…) Continue Reading »

Pharmaceuticals: How Obama Deal and New Approach Could Refresh ETFs
June 22, 2009 – The pharmaceutical industry and exchange traded funds are poised for some big changes as President Barack Obama closes loopholes and drug companies change drug development tactics. (more…) Continue Reading »

Where Are ETF Values In a Market That Makes No Sense?
March 5, 2009 – We all know that this recession is a deep one; the mystery here is how deep. Will the markets begin to make sense again for exchange traded fund (ETF) investors anytime in the near future? (more…) Continue Reading »

Health Care ETFs Forced To The Back Of The Line
October 8, 2008 – Congress and the nest presidential administration will have their hands tied dealing with the current economic crisis, which could very well force health care reforms to the back burner, as exchange traded funds (ETFs) cool... Continue Reading »

Healthcare ETFs Are Pulsing Amid Dire Conditions
September 4, 2008 – Health care and related exchange traded funds (ETFs) have remained on a steady beat while the rest of the market has faced challenges. With the coming election in November, everyone’s wondering what will become of healthcare... Continue Reading »

Success Of Cancer Vaccines Could Have Pharm ETFs Feeling Good
August 23, 2008 – With drug makers making a push for cervical cancer vaccination, the industry is quickly growing and certain ETFs can capture this growth. In a New York Times article, Elisabeth Rosenthal examines how over the past two... Continue Reading »

Pharmaceutical ETFs Mixed After Inconclusive Dementia Drug Study
July 30, 2008 – Exchange traded funds (ETFs) surrounding pharmaceutical companies appear to be mixed up as findings from advanced drug studies pertaining to dementia are inconclusive. Both Elan Corp. (ELN) and Wyeth (WYE) said complete data from the midstage... Continue Reading »